|
AU3224997A
|
|
Prodrugs of thalidomide and methods for using same as modulators of t-cell function
|
|
US5714484A
|
|
α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
|
|
US5486623A
|
|
Cysteine protease inhibitors containing heterocyclic leaving groups
|
|
US5374623A
|
|
Cysteine protease inhibitors effective for in vivo use
|
|
US5210272A
|
|
Process for forming a fluoromethyl ketone
|
|
US5101068A
|
|
Magnesium fluoromalonates
|
|
US4908309A
|
|
Method of detecting cysteine proteases
|
